Project Report - Phase I (as of September 25, 2013)
Phase I of the developmental plan for the Dr. Robert E. Carroll and Jane Chace Carroll Laboratories concluded with a bang! An informal groundbreaking ceremony on September 23rd featured Drs. Louis U. Bigliani and Francis Y. Lee initiating the renovation stage by shattering a wall in the old laboratory.
Phase I goals were met with great success. The vision of a musculoskeletal clinical and transitional research center was shared with colleagues throughout New York Presbyterian Hospital/Columbia University complexes. The enthusiastic response resulted in a May 10th Musculoskeletal Symposium on Current Trends in Musculoskeletal Medicine & Science spearheaded by Drs. Lee and Bigliani. Guest speakers represented the fields of orthopedic surgery, medicine, genetics and development, pathology and cell biology, hematology and oncology, endocrinology, rheumatology and regenerative medicine. The symposium's overall message was one of fostering collaborative clinical and transitional musculoskeletal research that would ultimately improve patient outcomes. The NYPress, New York Presbyterian's monthly magazine magazine featured an article on the symposium entitled "Expanding Collaborations in Musculoskeletal Medicine."
The Department of Orthopedic Surgery had a stellar year for research funding awards from private foundations and government agencies. In particular, Dr. Francis Lee receive an established investigator award from the Musculoskeletal Transplant Foundation and renewal of two NIH R01 awards. Dr. Charla Fischer received a NIH supplements award through mentor, Dr. Francis Lee's parent NIH grant.
Dr. Lee's recognition as an NIH principal investigator and mentor and Dr. Bigliani's roles as Departmental Chairman and President of ColumbiaDoctors have helped to establish the department's leadership position in the field of musculoskeletal research. More than 50 Principal Investigators with 60 NIH awards are conducting musculoskeletal system-related research spanning basic, translational, and clinical aspects at New York Presbyterian/Columbia University Medical Center.
The Dr. Robert E. Carroll and Jane Chace Carroll Laboratories will provide a solid foundation for cultivating a multidisciplinary musculoskeletal research center. This past July, Drs. Lee and Bigliani collaborated with more than 60 investigators for a P30 Center grant submission to the NIH. The long-term objectives of the P30 grant echo the Dr. Robert E. Carroll and Jane Chace Carroll Laboratories' goal to develop a musculoskeletal research center that will share rapidly evolving state-of-the-art core services to enhance collaborations for creative interdisciplinary research.
As we enter the renovation period, we will continue to develop collaborative relationships with our colleagues to advance clinical and transitional muscuoskeletal research. In addition, we will seek funding opportunities through private foundations, government awards and fund-raising activities. We eargerly welcome the next phase of development and look forward to a mew era in musculoskeletal research.